Table 4 Cardiopulmonary exercise testing data in the control and long COVID groups
From: Carotid body dysregulation contributes to Long COVID symptoms
CPET data | Controls (n = 14) | Long COVID (n = 14) | P-value |
|---|---|---|---|
HR at peak (beats/min) | 170 ± 17 | 158 ± 18 | 0.0619 |
(% predicted) | 97 ± 6 | 92 ± 9 | 0.1326 |
VO2 at peak (L/min) | 1.78 ± 0.57 | 1.40 ± 0.34 | 0.0378 |
(mL/kg/min) | 26.7 ± 7.4 | 18.6 ± 4.7 | 0.0015 |
(% predicted) | 91 ± 18 | 76 ± 18 | 0.0340 |
HR/%VO2 slope | 1.00 ± 0.15 | 0.77 ± 0.26 | 0.0114 |
RER at peak | 1.28 ± 0.11 | 1.27 ± 0.09 | 0.7483 |
RPE at peak (median, IQR) | 17 (16-18) | 19 (18-19) | 0.0081* |
Dyspnoea at peak (median, IQR) | 5 (4-8) | 8 (5-9) | 0.0515* |
SpO2 (%) at peak | 99 ± 1 | 99 ± 1 | 0.8966 |
VCO2 at peak (L/min) | 2.29 ± 0.83 | 1.76 ± 0.52 | 0.0477 |
PETCO2 at peak | 39.6 ± 4.7 | 33.6 ± 3.8 | 0.0007 |
O2 pulse peak (mL/beat) | 10.6 ± 2.8 | 8.9 ± 2.0 | 0.0650 |
Peak SBP (mmHg) | 177 ± 21 | 171 ± 26 | 0.5115 |
Peak DBP (mmHg) | 88 ± 12 | 90 ± 15 | 0.6286 |
VE at peak (L/min) | 71.5 ± 29.2 | 66.4 ± 22.4 | 0.6012 |
Breathing reserve | 43 ± 18 | 42 ± 24 | 0.8708 |
fB at peak (breaths/min) | 36 ± 10 | 37 ± 9 | 0.8705 |
VT at peak (L) | 1.98 ± 0.47 | 1.83 ± 0.40 | 0.3440 |
VE/VCO2 ratio at peak | 31.4 ± 4.9 | 38.7 ± 5.4 | 0.0005 |
VE/VO2 ratio at peak | 39.8 ± 7.6 | 48.4 ± 8.6 | 0.0095 |
VE/VCO2 slope | 27.7 ± 4.8 | 37.8 ± 4.4 | 0.0003 |
Nadir VE/VCO2 | 25.0 ± 2.4 | 30.1 ± 5.0 | 0.0020 |
VO2 at AT (mL/kg/min) | 18.7 ± 5.6 | 12.6 ± 4.3 | 0.0025 |
(% of VO2 peak) | 68 ± 10 | 66 ± 13 | 0.6490 |
PETCO2 at AT (mmHg) | 44 ± 4 | 38 ± 6 | 0.0041 |
VE/VCO2 at AT | 25.5 ± 2.4 | 30.4 ± 5.4 | 0.0042 |
HR at AT (beats/min | 132 ± 13 | 121 ± 15 | 0.0453 |
(% of peak HR) | 76 ± 5 | 77 ± 8 | 0.6181 |
Δ from rest (beats/min) | 61 ± 18 | 38 ± 16 | 0.0009 |
VO2/WR slope | 8.2 ± 1.2 | 8.2 ± 1.5 | 0.9283 |
Heart rate recovery 1 min (beats/min) | 19 ± 7 | 17 ± 5 | 0.4635 |